Medical Care
Global POCT Molecular Diagnostics Technology Market Research Report 2025
- Mar 14, 25
- ID: 133056
- Pages: 86
- Figures: 87
- Views: 55
The global market for POCT Molecular Diagnostics Technology was valued at US$ 5833 million in the year 2024 and is projected to reach a revised size of US$ 11000 million by 2031, growing at a CAGR of 9.6% during the forecast period.
Molecular POCT refers to a molecular biology detection system that is fully automated and integrated through technological innovation and optimization to meet the requirements of point-of-care testing (POCT). This system is an integrated closed system, and its nucleic acid extraction and amplification detection are all completed on the same closed, portable instrument, without the need for manual preparation of reagents or manual sample processing. No other manual operations are required from the time the sample is loaded on the machine to the result report, which can effectively prevent biological samples and their genetic materials from polluting the environment. It also has the characteristics of miniaturization, easy to carry, automation, full closure, fast speed, and easy operation. At the same time, it can ensure the high specificity and sensitivity of the detection performance, making it suitable for a variety of inspection scenarios such as hospital emergency, primary medical units, families, customs, and sudden disaster sites.
The growth of the molecular POCT (point-of-care testing) diagnostics market is driven by a number of drivers. First, the global prevalence of infectious diseases and the growing problem of antibiotic resistance have increased the demand for rapid and accurate molecular diagnostics. Molecular POCT can quickly detect pathogens on site and provide reliable results, reducing waiting time and helping medical staff to be more efficient in infection control and treatment decisions. In addition, technological advances have improved the convenience and detection range of molecular POCT systems, promoting their widespread use in primary care institutions, emergency rooms and telemedicine to meet the needs of decentralized medical care.
However, the molecular POCT market still faces some limiting factors. High costs and technical complexity are barriers to promotion in many regions, especially in resource-poor developing markets. In addition, although molecular POCT can provide results quickly, its accuracy may not be as good as laboratory testing in complex pathological conditions, limiting its application in certain high-precision demand environments. Strict regulatory requirements are also a major challenge. The complex approval process for medical devices in various countries may extend the time to market and affect the expansion speed of the market.
In terms of international market share and ranking, the main manufacturers are Danaher (Cepe), Roche, Abbott, bioMérieux, Hologic, Thermo Fisher, Bio-Tech, Bio-Bio, Shengxiang Bio, Cayoudi, Hangzhou Ustar, etc. In 2023, the top five manufacturers accounted for about 94% of the international market.
Molecular POCT (Point-of-Care Testing) diagnosis is showing a rapid growth trend in the global medical market. With the outbreak of the new crown epidemic, the demand for molecular POCT has been unprecedentedly promoted. Molecular POCT technology enables disease detection to shift from traditional laboratory processes to immediate and convenient on-site testing, reducing the waiting time for testing and improving diagnostic efficiency. The increasing popularity of portable and rapid molecular testing equipment in primary care and remote areas has enabled high-precision molecular testing to be performed in places with insufficient medical resources. The development of such products has made the detection of infectious diseases (such as influenza, tuberculosis, sexually transmitted diseases, etc.) more convenient and improved public health.
As the molecular POCT market continues to expand, technological innovation is also accelerating. The application of emerging technologies such as nanomaterials, microfluidics, and CRISPR has promoted the miniaturization of molecular POCT devices and improved detection sensitivity, making the test results more accurate and faster. In addition, with the application of AI and the Internet of Things, the data management and analysis capabilities of molecular POCT devices have also been significantly enhanced, enabling them to be combined with telemedicine and cloud data sharing to bring more intelligent medical solutions. These technological advances have promoted the global application of molecular POCT, thereby improving the efficiency of disease prevention and public health management.
This report aims to provide a comprehensive presentation of the global market for POCT Molecular Diagnostics Technology, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding POCT Molecular Diagnostics Technology.
The POCT Molecular Diagnostics Technology market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global POCT Molecular Diagnostics Technology market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the POCT Molecular Diagnostics Technology companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Danaher (Cepheid)
Roche
Abbott
bioMérieux
Hologic
Thermo Fisher Scientific
Bohui Innovation
AoBio
Shengxiang Bio
Kayoudi
Hangzhou Yousda
Segment by Type
Reagents Consumables
Equipment
Other
Segment by Application
Hospital
Decentralized Laboratory
Other
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of POCT Molecular Diagnostics Technology company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Molecular POCT refers to a molecular biology detection system that is fully automated and integrated through technological innovation and optimization to meet the requirements of point-of-care testing (POCT). This system is an integrated closed system, and its nucleic acid extraction and amplification detection are all completed on the same closed, portable instrument, without the need for manual preparation of reagents or manual sample processing. No other manual operations are required from the time the sample is loaded on the machine to the result report, which can effectively prevent biological samples and their genetic materials from polluting the environment. It also has the characteristics of miniaturization, easy to carry, automation, full closure, fast speed, and easy operation. At the same time, it can ensure the high specificity and sensitivity of the detection performance, making it suitable for a variety of inspection scenarios such as hospital emergency, primary medical units, families, customs, and sudden disaster sites.
The growth of the molecular POCT (point-of-care testing) diagnostics market is driven by a number of drivers. First, the global prevalence of infectious diseases and the growing problem of antibiotic resistance have increased the demand for rapid and accurate molecular diagnostics. Molecular POCT can quickly detect pathogens on site and provide reliable results, reducing waiting time and helping medical staff to be more efficient in infection control and treatment decisions. In addition, technological advances have improved the convenience and detection range of molecular POCT systems, promoting their widespread use in primary care institutions, emergency rooms and telemedicine to meet the needs of decentralized medical care.
However, the molecular POCT market still faces some limiting factors. High costs and technical complexity are barriers to promotion in many regions, especially in resource-poor developing markets. In addition, although molecular POCT can provide results quickly, its accuracy may not be as good as laboratory testing in complex pathological conditions, limiting its application in certain high-precision demand environments. Strict regulatory requirements are also a major challenge. The complex approval process for medical devices in various countries may extend the time to market and affect the expansion speed of the market.
In terms of international market share and ranking, the main manufacturers are Danaher (Cepe), Roche, Abbott, bioMérieux, Hologic, Thermo Fisher, Bio-Tech, Bio-Bio, Shengxiang Bio, Cayoudi, Hangzhou Ustar, etc. In 2023, the top five manufacturers accounted for about 94% of the international market.
Molecular POCT (Point-of-Care Testing) diagnosis is showing a rapid growth trend in the global medical market. With the outbreak of the new crown epidemic, the demand for molecular POCT has been unprecedentedly promoted. Molecular POCT technology enables disease detection to shift from traditional laboratory processes to immediate and convenient on-site testing, reducing the waiting time for testing and improving diagnostic efficiency. The increasing popularity of portable and rapid molecular testing equipment in primary care and remote areas has enabled high-precision molecular testing to be performed in places with insufficient medical resources. The development of such products has made the detection of infectious diseases (such as influenza, tuberculosis, sexually transmitted diseases, etc.) more convenient and improved public health.
As the molecular POCT market continues to expand, technological innovation is also accelerating. The application of emerging technologies such as nanomaterials, microfluidics, and CRISPR has promoted the miniaturization of molecular POCT devices and improved detection sensitivity, making the test results more accurate and faster. In addition, with the application of AI and the Internet of Things, the data management and analysis capabilities of molecular POCT devices have also been significantly enhanced, enabling them to be combined with telemedicine and cloud data sharing to bring more intelligent medical solutions. These technological advances have promoted the global application of molecular POCT, thereby improving the efficiency of disease prevention and public health management.
This report aims to provide a comprehensive presentation of the global market for POCT Molecular Diagnostics Technology, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding POCT Molecular Diagnostics Technology.
The POCT Molecular Diagnostics Technology market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global POCT Molecular Diagnostics Technology market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the POCT Molecular Diagnostics Technology companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Danaher (Cepheid)
Roche
Abbott
bioMérieux
Hologic
Thermo Fisher Scientific
Bohui Innovation
AoBio
Shengxiang Bio
Kayoudi
Hangzhou Yousda
Segment by Type
Reagents Consumables
Equipment
Other
Segment by Application
Hospital
Decentralized Laboratory
Other
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of POCT Molecular Diagnostics Technology company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global POCT Molecular Diagnostics Technology Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Reagents Consumables
1.2.3 Equipment
1.2.4 Other
1.3 Market by Application
1.3.1 Global POCT Molecular Diagnostics Technology Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Decentralized Laboratory
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global POCT Molecular Diagnostics Technology Market Perspective (2020-2031)
2.2 Global POCT Molecular Diagnostics Technology Growth Trends by Region
2.2.1 Global POCT Molecular Diagnostics Technology Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 POCT Molecular Diagnostics Technology Historic Market Size by Region (2020-2025)
2.2.3 POCT Molecular Diagnostics Technology Forecasted Market Size by Region (2026-2031)
2.3 POCT Molecular Diagnostics Technology Market Dynamics
2.3.1 POCT Molecular Diagnostics Technology Industry Trends
2.3.2 POCT Molecular Diagnostics Technology Market Drivers
2.3.3 POCT Molecular Diagnostics Technology Market Challenges
2.3.4 POCT Molecular Diagnostics Technology Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top POCT Molecular Diagnostics Technology Players by Revenue
3.1.1 Global Top POCT Molecular Diagnostics Technology Players by Revenue (2020-2025)
3.1.2 Global POCT Molecular Diagnostics Technology Revenue Market Share by Players (2020-2025)
3.2 Global POCT Molecular Diagnostics Technology Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by POCT Molecular Diagnostics Technology Revenue
3.4 Global POCT Molecular Diagnostics Technology Market Concentration Ratio
3.4.1 Global POCT Molecular Diagnostics Technology Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by POCT Molecular Diagnostics Technology Revenue in 2024
3.5 Global Key Players of POCT Molecular Diagnostics Technology Head office and Area Served
3.6 Global Key Players of POCT Molecular Diagnostics Technology, Product and Application
3.7 Global Key Players of POCT Molecular Diagnostics Technology, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 POCT Molecular Diagnostics Technology Breakdown Data by Type
4.1 Global POCT Molecular Diagnostics Technology Historic Market Size by Type (2020-2025)
4.2 Global POCT Molecular Diagnostics Technology Forecasted Market Size by Type (2026-2031)
5 POCT Molecular Diagnostics Technology Breakdown Data by Application
5.1 Global POCT Molecular Diagnostics Technology Historic Market Size by Application (2020-2025)
5.2 Global POCT Molecular Diagnostics Technology Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America POCT Molecular Diagnostics Technology Market Size (2020-2031)
6.2 North America POCT Molecular Diagnostics Technology Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America POCT Molecular Diagnostics Technology Market Size by Country (2020-2025)
6.4 North America POCT Molecular Diagnostics Technology Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe POCT Molecular Diagnostics Technology Market Size (2020-2031)
7.2 Europe POCT Molecular Diagnostics Technology Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe POCT Molecular Diagnostics Technology Market Size by Country (2020-2025)
7.4 Europe POCT Molecular Diagnostics Technology Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific POCT Molecular Diagnostics Technology Market Size (2020-2031)
8.2 Asia-Pacific POCT Molecular Diagnostics Technology Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific POCT Molecular Diagnostics Technology Market Size by Region (2020-2025)
8.4 Asia-Pacific POCT Molecular Diagnostics Technology Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America POCT Molecular Diagnostics Technology Market Size (2020-2031)
9.2 Latin America POCT Molecular Diagnostics Technology Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America POCT Molecular Diagnostics Technology Market Size by Country (2020-2025)
9.4 Latin America POCT Molecular Diagnostics Technology Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa POCT Molecular Diagnostics Technology Market Size (2020-2031)
10.2 Middle East & Africa POCT Molecular Diagnostics Technology Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa POCT Molecular Diagnostics Technology Market Size by Country (2020-2025)
10.4 Middle East & Africa POCT Molecular Diagnostics Technology Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Danaher (Cepheid)
11.1.1 Danaher (Cepheid) Company Details
11.1.2 Danaher (Cepheid) Business Overview
11.1.3 Danaher (Cepheid) POCT Molecular Diagnostics Technology Introduction
11.1.4 Danaher (Cepheid) Revenue in POCT Molecular Diagnostics Technology Business (2020-2025)
11.1.5 Danaher (Cepheid) Recent Development
11.2 Roche
11.2.1 Roche Company Details
11.2.2 Roche Business Overview
11.2.3 Roche POCT Molecular Diagnostics Technology Introduction
11.2.4 Roche Revenue in POCT Molecular Diagnostics Technology Business (2020-2025)
11.2.5 Roche Recent Development
11.3 Abbott
11.3.1 Abbott Company Details
11.3.2 Abbott Business Overview
11.3.3 Abbott POCT Molecular Diagnostics Technology Introduction
11.3.4 Abbott Revenue in POCT Molecular Diagnostics Technology Business (2020-2025)
11.3.5 Abbott Recent Development
11.4 bioMérieux
11.4.1 bioMérieux Company Details
11.4.2 bioMérieux Business Overview
11.4.3 bioMérieux POCT Molecular Diagnostics Technology Introduction
11.4.4 bioMérieux Revenue in POCT Molecular Diagnostics Technology Business (2020-2025)
11.4.5 bioMérieux Recent Development
11.5 Hologic
11.5.1 Hologic Company Details
11.5.2 Hologic Business Overview
11.5.3 Hologic POCT Molecular Diagnostics Technology Introduction
11.5.4 Hologic Revenue in POCT Molecular Diagnostics Technology Business (2020-2025)
11.5.5 Hologic Recent Development
11.6 Thermo Fisher Scientific
11.6.1 Thermo Fisher Scientific Company Details
11.6.2 Thermo Fisher Scientific Business Overview
11.6.3 Thermo Fisher Scientific POCT Molecular Diagnostics Technology Introduction
11.6.4 Thermo Fisher Scientific Revenue in POCT Molecular Diagnostics Technology Business (2020-2025)
11.6.5 Thermo Fisher Scientific Recent Development
11.7 Bohui Innovation
11.7.1 Bohui Innovation Company Details
11.7.2 Bohui Innovation Business Overview
11.7.3 Bohui Innovation POCT Molecular Diagnostics Technology Introduction
11.7.4 Bohui Innovation Revenue in POCT Molecular Diagnostics Technology Business (2020-2025)
11.7.5 Bohui Innovation Recent Development
11.8 AoBio
11.8.1 AoBio Company Details
11.8.2 AoBio Business Overview
11.8.3 AoBio POCT Molecular Diagnostics Technology Introduction
11.8.4 AoBio Revenue in POCT Molecular Diagnostics Technology Business (2020-2025)
11.8.5 AoBio Recent Development
11.9 Shengxiang Bio
11.9.1 Shengxiang Bio Company Details
11.9.2 Shengxiang Bio Business Overview
11.9.3 Shengxiang Bio POCT Molecular Diagnostics Technology Introduction
11.9.4 Shengxiang Bio Revenue in POCT Molecular Diagnostics Technology Business (2020-2025)
11.9.5 Shengxiang Bio Recent Development
11.10 Kayoudi
11.10.1 Kayoudi Company Details
11.10.2 Kayoudi Business Overview
11.10.3 Kayoudi POCT Molecular Diagnostics Technology Introduction
11.10.4 Kayoudi Revenue in POCT Molecular Diagnostics Technology Business (2020-2025)
11.10.5 Kayoudi Recent Development
11.11 Hangzhou Yousda
11.11.1 Hangzhou Yousda Company Details
11.11.2 Hangzhou Yousda Business Overview
11.11.3 Hangzhou Yousda POCT Molecular Diagnostics Technology Introduction
11.11.4 Hangzhou Yousda Revenue in POCT Molecular Diagnostics Technology Business (2020-2025)
11.11.5 Hangzhou Yousda Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global POCT Molecular Diagnostics Technology Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Reagents Consumables
1.2.3 Equipment
1.2.4 Other
1.3 Market by Application
1.3.1 Global POCT Molecular Diagnostics Technology Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Decentralized Laboratory
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global POCT Molecular Diagnostics Technology Market Perspective (2020-2031)
2.2 Global POCT Molecular Diagnostics Technology Growth Trends by Region
2.2.1 Global POCT Molecular Diagnostics Technology Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 POCT Molecular Diagnostics Technology Historic Market Size by Region (2020-2025)
2.2.3 POCT Molecular Diagnostics Technology Forecasted Market Size by Region (2026-2031)
2.3 POCT Molecular Diagnostics Technology Market Dynamics
2.3.1 POCT Molecular Diagnostics Technology Industry Trends
2.3.2 POCT Molecular Diagnostics Technology Market Drivers
2.3.3 POCT Molecular Diagnostics Technology Market Challenges
2.3.4 POCT Molecular Diagnostics Technology Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top POCT Molecular Diagnostics Technology Players by Revenue
3.1.1 Global Top POCT Molecular Diagnostics Technology Players by Revenue (2020-2025)
3.1.2 Global POCT Molecular Diagnostics Technology Revenue Market Share by Players (2020-2025)
3.2 Global POCT Molecular Diagnostics Technology Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by POCT Molecular Diagnostics Technology Revenue
3.4 Global POCT Molecular Diagnostics Technology Market Concentration Ratio
3.4.1 Global POCT Molecular Diagnostics Technology Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by POCT Molecular Diagnostics Technology Revenue in 2024
3.5 Global Key Players of POCT Molecular Diagnostics Technology Head office and Area Served
3.6 Global Key Players of POCT Molecular Diagnostics Technology, Product and Application
3.7 Global Key Players of POCT Molecular Diagnostics Technology, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 POCT Molecular Diagnostics Technology Breakdown Data by Type
4.1 Global POCT Molecular Diagnostics Technology Historic Market Size by Type (2020-2025)
4.2 Global POCT Molecular Diagnostics Technology Forecasted Market Size by Type (2026-2031)
5 POCT Molecular Diagnostics Technology Breakdown Data by Application
5.1 Global POCT Molecular Diagnostics Technology Historic Market Size by Application (2020-2025)
5.2 Global POCT Molecular Diagnostics Technology Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America POCT Molecular Diagnostics Technology Market Size (2020-2031)
6.2 North America POCT Molecular Diagnostics Technology Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America POCT Molecular Diagnostics Technology Market Size by Country (2020-2025)
6.4 North America POCT Molecular Diagnostics Technology Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe POCT Molecular Diagnostics Technology Market Size (2020-2031)
7.2 Europe POCT Molecular Diagnostics Technology Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe POCT Molecular Diagnostics Technology Market Size by Country (2020-2025)
7.4 Europe POCT Molecular Diagnostics Technology Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific POCT Molecular Diagnostics Technology Market Size (2020-2031)
8.2 Asia-Pacific POCT Molecular Diagnostics Technology Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific POCT Molecular Diagnostics Technology Market Size by Region (2020-2025)
8.4 Asia-Pacific POCT Molecular Diagnostics Technology Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America POCT Molecular Diagnostics Technology Market Size (2020-2031)
9.2 Latin America POCT Molecular Diagnostics Technology Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America POCT Molecular Diagnostics Technology Market Size by Country (2020-2025)
9.4 Latin America POCT Molecular Diagnostics Technology Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa POCT Molecular Diagnostics Technology Market Size (2020-2031)
10.2 Middle East & Africa POCT Molecular Diagnostics Technology Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa POCT Molecular Diagnostics Technology Market Size by Country (2020-2025)
10.4 Middle East & Africa POCT Molecular Diagnostics Technology Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Danaher (Cepheid)
11.1.1 Danaher (Cepheid) Company Details
11.1.2 Danaher (Cepheid) Business Overview
11.1.3 Danaher (Cepheid) POCT Molecular Diagnostics Technology Introduction
11.1.4 Danaher (Cepheid) Revenue in POCT Molecular Diagnostics Technology Business (2020-2025)
11.1.5 Danaher (Cepheid) Recent Development
11.2 Roche
11.2.1 Roche Company Details
11.2.2 Roche Business Overview
11.2.3 Roche POCT Molecular Diagnostics Technology Introduction
11.2.4 Roche Revenue in POCT Molecular Diagnostics Technology Business (2020-2025)
11.2.5 Roche Recent Development
11.3 Abbott
11.3.1 Abbott Company Details
11.3.2 Abbott Business Overview
11.3.3 Abbott POCT Molecular Diagnostics Technology Introduction
11.3.4 Abbott Revenue in POCT Molecular Diagnostics Technology Business (2020-2025)
11.3.5 Abbott Recent Development
11.4 bioMérieux
11.4.1 bioMérieux Company Details
11.4.2 bioMérieux Business Overview
11.4.3 bioMérieux POCT Molecular Diagnostics Technology Introduction
11.4.4 bioMérieux Revenue in POCT Molecular Diagnostics Technology Business (2020-2025)
11.4.5 bioMérieux Recent Development
11.5 Hologic
11.5.1 Hologic Company Details
11.5.2 Hologic Business Overview
11.5.3 Hologic POCT Molecular Diagnostics Technology Introduction
11.5.4 Hologic Revenue in POCT Molecular Diagnostics Technology Business (2020-2025)
11.5.5 Hologic Recent Development
11.6 Thermo Fisher Scientific
11.6.1 Thermo Fisher Scientific Company Details
11.6.2 Thermo Fisher Scientific Business Overview
11.6.3 Thermo Fisher Scientific POCT Molecular Diagnostics Technology Introduction
11.6.4 Thermo Fisher Scientific Revenue in POCT Molecular Diagnostics Technology Business (2020-2025)
11.6.5 Thermo Fisher Scientific Recent Development
11.7 Bohui Innovation
11.7.1 Bohui Innovation Company Details
11.7.2 Bohui Innovation Business Overview
11.7.3 Bohui Innovation POCT Molecular Diagnostics Technology Introduction
11.7.4 Bohui Innovation Revenue in POCT Molecular Diagnostics Technology Business (2020-2025)
11.7.5 Bohui Innovation Recent Development
11.8 AoBio
11.8.1 AoBio Company Details
11.8.2 AoBio Business Overview
11.8.3 AoBio POCT Molecular Diagnostics Technology Introduction
11.8.4 AoBio Revenue in POCT Molecular Diagnostics Technology Business (2020-2025)
11.8.5 AoBio Recent Development
11.9 Shengxiang Bio
11.9.1 Shengxiang Bio Company Details
11.9.2 Shengxiang Bio Business Overview
11.9.3 Shengxiang Bio POCT Molecular Diagnostics Technology Introduction
11.9.4 Shengxiang Bio Revenue in POCT Molecular Diagnostics Technology Business (2020-2025)
11.9.5 Shengxiang Bio Recent Development
11.10 Kayoudi
11.10.1 Kayoudi Company Details
11.10.2 Kayoudi Business Overview
11.10.3 Kayoudi POCT Molecular Diagnostics Technology Introduction
11.10.4 Kayoudi Revenue in POCT Molecular Diagnostics Technology Business (2020-2025)
11.10.5 Kayoudi Recent Development
11.11 Hangzhou Yousda
11.11.1 Hangzhou Yousda Company Details
11.11.2 Hangzhou Yousda Business Overview
11.11.3 Hangzhou Yousda POCT Molecular Diagnostics Technology Introduction
11.11.4 Hangzhou Yousda Revenue in POCT Molecular Diagnostics Technology Business (2020-2025)
11.11.5 Hangzhou Yousda Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global POCT Molecular Diagnostics Technology Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Reagents Consumables
Table 3. Key Players of Equipment
Table 4. Key Players of Other
Table 5. Global POCT Molecular Diagnostics Technology Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global POCT Molecular Diagnostics Technology Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global POCT Molecular Diagnostics Technology Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global POCT Molecular Diagnostics Technology Market Share by Region (2020-2025)
Table 9. Global POCT Molecular Diagnostics Technology Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global POCT Molecular Diagnostics Technology Market Share by Region (2026-2031)
Table 11. POCT Molecular Diagnostics Technology Market Trends
Table 12. POCT Molecular Diagnostics Technology Market Drivers
Table 13. POCT Molecular Diagnostics Technology Market Challenges
Table 14. POCT Molecular Diagnostics Technology Market Restraints
Table 15. Global POCT Molecular Diagnostics Technology Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global POCT Molecular Diagnostics Technology Market Share by Players (2020-2025)
Table 17. Global Top POCT Molecular Diagnostics Technology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in POCT Molecular Diagnostics Technology as of 2024)
Table 18. Ranking of Global Top POCT Molecular Diagnostics Technology Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by POCT Molecular Diagnostics Technology Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of POCT Molecular Diagnostics Technology, Headquarters and Area Served
Table 21. Global Key Players of POCT Molecular Diagnostics Technology, Product and Application
Table 22. Global Key Players of POCT Molecular Diagnostics Technology, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global POCT Molecular Diagnostics Technology Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global POCT Molecular Diagnostics Technology Revenue Market Share by Type (2020-2025)
Table 26. Global POCT Molecular Diagnostics Technology Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global POCT Molecular Diagnostics Technology Revenue Market Share by Type (2026-2031)
Table 28. Global POCT Molecular Diagnostics Technology Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global POCT Molecular Diagnostics Technology Revenue Market Share by Application (2020-2025)
Table 30. Global POCT Molecular Diagnostics Technology Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global POCT Molecular Diagnostics Technology Revenue Market Share by Application (2026-2031)
Table 32. North America POCT Molecular Diagnostics Technology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America POCT Molecular Diagnostics Technology Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America POCT Molecular Diagnostics Technology Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe POCT Molecular Diagnostics Technology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe POCT Molecular Diagnostics Technology Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe POCT Molecular Diagnostics Technology Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific POCT Molecular Diagnostics Technology Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific POCT Molecular Diagnostics Technology Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific POCT Molecular Diagnostics Technology Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America POCT Molecular Diagnostics Technology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America POCT Molecular Diagnostics Technology Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America POCT Molecular Diagnostics Technology Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa POCT Molecular Diagnostics Technology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa POCT Molecular Diagnostics Technology Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa POCT Molecular Diagnostics Technology Market Size by Country (2026-2031) & (US$ Million)
Table 47. Danaher (Cepheid) Company Details
Table 48. Danaher (Cepheid) Business Overview
Table 49. Danaher (Cepheid) POCT Molecular Diagnostics Technology Product
Table 50. Danaher (Cepheid) Revenue in POCT Molecular Diagnostics Technology Business (2020-2025) & (US$ Million)
Table 51. Danaher (Cepheid) Recent Development
Table 52. Roche Company Details
Table 53. Roche Business Overview
Table 54. Roche POCT Molecular Diagnostics Technology Product
Table 55. Roche Revenue in POCT Molecular Diagnostics Technology Business (2020-2025) & (US$ Million)
Table 56. Roche Recent Development
Table 57. Abbott Company Details
Table 58. Abbott Business Overview
Table 59. Abbott POCT Molecular Diagnostics Technology Product
Table 60. Abbott Revenue in POCT Molecular Diagnostics Technology Business (2020-2025) & (US$ Million)
Table 61. Abbott Recent Development
Table 62. bioMérieux Company Details
Table 63. bioMérieux Business Overview
Table 64. bioMérieux POCT Molecular Diagnostics Technology Product
Table 65. bioMérieux Revenue in POCT Molecular Diagnostics Technology Business (2020-2025) & (US$ Million)
Table 66. bioMérieux Recent Development
Table 67. Hologic Company Details
Table 68. Hologic Business Overview
Table 69. Hologic POCT Molecular Diagnostics Technology Product
Table 70. Hologic Revenue in POCT Molecular Diagnostics Technology Business (2020-2025) & (US$ Million)
Table 71. Hologic Recent Development
Table 72. Thermo Fisher Scientific Company Details
Table 73. Thermo Fisher Scientific Business Overview
Table 74. Thermo Fisher Scientific POCT Molecular Diagnostics Technology Product
Table 75. Thermo Fisher Scientific Revenue in POCT Molecular Diagnostics Technology Business (2020-2025) & (US$ Million)
Table 76. Thermo Fisher Scientific Recent Development
Table 77. Bohui Innovation Company Details
Table 78. Bohui Innovation Business Overview
Table 79. Bohui Innovation POCT Molecular Diagnostics Technology Product
Table 80. Bohui Innovation Revenue in POCT Molecular Diagnostics Technology Business (2020-2025) & (US$ Million)
Table 81. Bohui Innovation Recent Development
Table 82. AoBio Company Details
Table 83. AoBio Business Overview
Table 84. AoBio POCT Molecular Diagnostics Technology Product
Table 85. AoBio Revenue in POCT Molecular Diagnostics Technology Business (2020-2025) & (US$ Million)
Table 86. AoBio Recent Development
Table 87. Shengxiang Bio Company Details
Table 88. Shengxiang Bio Business Overview
Table 89. Shengxiang Bio POCT Molecular Diagnostics Technology Product
Table 90. Shengxiang Bio Revenue in POCT Molecular Diagnostics Technology Business (2020-2025) & (US$ Million)
Table 91. Shengxiang Bio Recent Development
Table 92. Kayoudi Company Details
Table 93. Kayoudi Business Overview
Table 94. Kayoudi POCT Molecular Diagnostics Technology Product
Table 95. Kayoudi Revenue in POCT Molecular Diagnostics Technology Business (2020-2025) & (US$ Million)
Table 96. Kayoudi Recent Development
Table 97. Hangzhou Yousda Company Details
Table 98. Hangzhou Yousda Business Overview
Table 99. Hangzhou Yousda POCT Molecular Diagnostics Technology Product
Table 100. Hangzhou Yousda Revenue in POCT Molecular Diagnostics Technology Business (2020-2025) & (US$ Million)
Table 101. Hangzhou Yousda Recent Development
Table 102. Research Programs/Design for This Report
Table 103. Key Data Information from Secondary Sources
Table 104. Key Data Information from Primary Sources
Table 105. Authors List of This Report
List of Figures
Figure 1. POCT Molecular Diagnostics Technology Picture
Figure 2. Global POCT Molecular Diagnostics Technology Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global POCT Molecular Diagnostics Technology Market Share by Type: 2024 VS 2031
Figure 4. Reagents Consumables Features
Figure 5. Equipment Features
Figure 6. Other Features
Figure 7. Global POCT Molecular Diagnostics Technology Market Size by Application (2020-2031) & (US$ Million)
Figure 8. Global POCT Molecular Diagnostics Technology Market Share by Application: 2024 VS 2031
Figure 9. Hospital Case Studies
Figure 10. Decentralized Laboratory Case Studies
Figure 11. Other Case Studies
Figure 12. POCT Molecular Diagnostics Technology Report Years Considered
Figure 13. Global POCT Molecular Diagnostics Technology Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global POCT Molecular Diagnostics Technology Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global POCT Molecular Diagnostics Technology Market Share by Region: 2024 VS 2031
Figure 16. Global POCT Molecular Diagnostics Technology Market Share by Players in 2024
Figure 17. Global Top POCT Molecular Diagnostics Technology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in POCT Molecular Diagnostics Technology as of 2024)
Figure 18. The Top 10 and 5 Players Market Share by POCT Molecular Diagnostics Technology Revenue in 2024
Figure 19. North America POCT Molecular Diagnostics Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America POCT Molecular Diagnostics Technology Market Share by Country (2020-2031)
Figure 21. United States POCT Molecular Diagnostics Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada POCT Molecular Diagnostics Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe POCT Molecular Diagnostics Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe POCT Molecular Diagnostics Technology Market Share by Country (2020-2031)
Figure 25. Germany POCT Molecular Diagnostics Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France POCT Molecular Diagnostics Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. POCT Molecular Diagnostics Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy POCT Molecular Diagnostics Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia POCT Molecular Diagnostics Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Nordic Countries POCT Molecular Diagnostics Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific POCT Molecular Diagnostics Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific POCT Molecular Diagnostics Technology Market Share by Region (2020-2031)
Figure 33. China POCT Molecular Diagnostics Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan POCT Molecular Diagnostics Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea POCT Molecular Diagnostics Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia POCT Molecular Diagnostics Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India POCT Molecular Diagnostics Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia POCT Molecular Diagnostics Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America POCT Molecular Diagnostics Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America POCT Molecular Diagnostics Technology Market Share by Country (2020-2031)
Figure 41. Mexico POCT Molecular Diagnostics Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil POCT Molecular Diagnostics Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa POCT Molecular Diagnostics Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa POCT Molecular Diagnostics Technology Market Share by Country (2020-2031)
Figure 45. Turkey POCT Molecular Diagnostics Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia POCT Molecular Diagnostics Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. UAE POCT Molecular Diagnostics Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Danaher (Cepheid) Revenue Growth Rate in POCT Molecular Diagnostics Technology Business (2020-2025)
Figure 49. Roche Revenue Growth Rate in POCT Molecular Diagnostics Technology Business (2020-2025)
Figure 50. Abbott Revenue Growth Rate in POCT Molecular Diagnostics Technology Business (2020-2025)
Figure 51. bioMérieux Revenue Growth Rate in POCT Molecular Diagnostics Technology Business (2020-2025)
Figure 52. Hologic Revenue Growth Rate in POCT Molecular Diagnostics Technology Business (2020-2025)
Figure 53. Thermo Fisher Scientific Revenue Growth Rate in POCT Molecular Diagnostics Technology Business (2020-2025)
Figure 54. Bohui Innovation Revenue Growth Rate in POCT Molecular Diagnostics Technology Business (2020-2025)
Figure 55. AoBio Revenue Growth Rate in POCT Molecular Diagnostics Technology Business (2020-2025)
Figure 56. Shengxiang Bio Revenue Growth Rate in POCT Molecular Diagnostics Technology Business (2020-2025)
Figure 57. Kayoudi Revenue Growth Rate in POCT Molecular Diagnostics Technology Business (2020-2025)
Figure 58. Hangzhou Yousda Revenue Growth Rate in POCT Molecular Diagnostics Technology Business (2020-2025)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
Table 1. Global POCT Molecular Diagnostics Technology Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Reagents Consumables
Table 3. Key Players of Equipment
Table 4. Key Players of Other
Table 5. Global POCT Molecular Diagnostics Technology Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global POCT Molecular Diagnostics Technology Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global POCT Molecular Diagnostics Technology Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global POCT Molecular Diagnostics Technology Market Share by Region (2020-2025)
Table 9. Global POCT Molecular Diagnostics Technology Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global POCT Molecular Diagnostics Technology Market Share by Region (2026-2031)
Table 11. POCT Molecular Diagnostics Technology Market Trends
Table 12. POCT Molecular Diagnostics Technology Market Drivers
Table 13. POCT Molecular Diagnostics Technology Market Challenges
Table 14. POCT Molecular Diagnostics Technology Market Restraints
Table 15. Global POCT Molecular Diagnostics Technology Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global POCT Molecular Diagnostics Technology Market Share by Players (2020-2025)
Table 17. Global Top POCT Molecular Diagnostics Technology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in POCT Molecular Diagnostics Technology as of 2024)
Table 18. Ranking of Global Top POCT Molecular Diagnostics Technology Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by POCT Molecular Diagnostics Technology Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of POCT Molecular Diagnostics Technology, Headquarters and Area Served
Table 21. Global Key Players of POCT Molecular Diagnostics Technology, Product and Application
Table 22. Global Key Players of POCT Molecular Diagnostics Technology, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global POCT Molecular Diagnostics Technology Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global POCT Molecular Diagnostics Technology Revenue Market Share by Type (2020-2025)
Table 26. Global POCT Molecular Diagnostics Technology Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global POCT Molecular Diagnostics Technology Revenue Market Share by Type (2026-2031)
Table 28. Global POCT Molecular Diagnostics Technology Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global POCT Molecular Diagnostics Technology Revenue Market Share by Application (2020-2025)
Table 30. Global POCT Molecular Diagnostics Technology Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global POCT Molecular Diagnostics Technology Revenue Market Share by Application (2026-2031)
Table 32. North America POCT Molecular Diagnostics Technology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America POCT Molecular Diagnostics Technology Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America POCT Molecular Diagnostics Technology Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe POCT Molecular Diagnostics Technology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe POCT Molecular Diagnostics Technology Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe POCT Molecular Diagnostics Technology Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific POCT Molecular Diagnostics Technology Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific POCT Molecular Diagnostics Technology Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific POCT Molecular Diagnostics Technology Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America POCT Molecular Diagnostics Technology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America POCT Molecular Diagnostics Technology Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America POCT Molecular Diagnostics Technology Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa POCT Molecular Diagnostics Technology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa POCT Molecular Diagnostics Technology Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa POCT Molecular Diagnostics Technology Market Size by Country (2026-2031) & (US$ Million)
Table 47. Danaher (Cepheid) Company Details
Table 48. Danaher (Cepheid) Business Overview
Table 49. Danaher (Cepheid) POCT Molecular Diagnostics Technology Product
Table 50. Danaher (Cepheid) Revenue in POCT Molecular Diagnostics Technology Business (2020-2025) & (US$ Million)
Table 51. Danaher (Cepheid) Recent Development
Table 52. Roche Company Details
Table 53. Roche Business Overview
Table 54. Roche POCT Molecular Diagnostics Technology Product
Table 55. Roche Revenue in POCT Molecular Diagnostics Technology Business (2020-2025) & (US$ Million)
Table 56. Roche Recent Development
Table 57. Abbott Company Details
Table 58. Abbott Business Overview
Table 59. Abbott POCT Molecular Diagnostics Technology Product
Table 60. Abbott Revenue in POCT Molecular Diagnostics Technology Business (2020-2025) & (US$ Million)
Table 61. Abbott Recent Development
Table 62. bioMérieux Company Details
Table 63. bioMérieux Business Overview
Table 64. bioMérieux POCT Molecular Diagnostics Technology Product
Table 65. bioMérieux Revenue in POCT Molecular Diagnostics Technology Business (2020-2025) & (US$ Million)
Table 66. bioMérieux Recent Development
Table 67. Hologic Company Details
Table 68. Hologic Business Overview
Table 69. Hologic POCT Molecular Diagnostics Technology Product
Table 70. Hologic Revenue in POCT Molecular Diagnostics Technology Business (2020-2025) & (US$ Million)
Table 71. Hologic Recent Development
Table 72. Thermo Fisher Scientific Company Details
Table 73. Thermo Fisher Scientific Business Overview
Table 74. Thermo Fisher Scientific POCT Molecular Diagnostics Technology Product
Table 75. Thermo Fisher Scientific Revenue in POCT Molecular Diagnostics Technology Business (2020-2025) & (US$ Million)
Table 76. Thermo Fisher Scientific Recent Development
Table 77. Bohui Innovation Company Details
Table 78. Bohui Innovation Business Overview
Table 79. Bohui Innovation POCT Molecular Diagnostics Technology Product
Table 80. Bohui Innovation Revenue in POCT Molecular Diagnostics Technology Business (2020-2025) & (US$ Million)
Table 81. Bohui Innovation Recent Development
Table 82. AoBio Company Details
Table 83. AoBio Business Overview
Table 84. AoBio POCT Molecular Diagnostics Technology Product
Table 85. AoBio Revenue in POCT Molecular Diagnostics Technology Business (2020-2025) & (US$ Million)
Table 86. AoBio Recent Development
Table 87. Shengxiang Bio Company Details
Table 88. Shengxiang Bio Business Overview
Table 89. Shengxiang Bio POCT Molecular Diagnostics Technology Product
Table 90. Shengxiang Bio Revenue in POCT Molecular Diagnostics Technology Business (2020-2025) & (US$ Million)
Table 91. Shengxiang Bio Recent Development
Table 92. Kayoudi Company Details
Table 93. Kayoudi Business Overview
Table 94. Kayoudi POCT Molecular Diagnostics Technology Product
Table 95. Kayoudi Revenue in POCT Molecular Diagnostics Technology Business (2020-2025) & (US$ Million)
Table 96. Kayoudi Recent Development
Table 97. Hangzhou Yousda Company Details
Table 98. Hangzhou Yousda Business Overview
Table 99. Hangzhou Yousda POCT Molecular Diagnostics Technology Product
Table 100. Hangzhou Yousda Revenue in POCT Molecular Diagnostics Technology Business (2020-2025) & (US$ Million)
Table 101. Hangzhou Yousda Recent Development
Table 102. Research Programs/Design for This Report
Table 103. Key Data Information from Secondary Sources
Table 104. Key Data Information from Primary Sources
Table 105. Authors List of This Report
List of Figures
Figure 1. POCT Molecular Diagnostics Technology Picture
Figure 2. Global POCT Molecular Diagnostics Technology Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global POCT Molecular Diagnostics Technology Market Share by Type: 2024 VS 2031
Figure 4. Reagents Consumables Features
Figure 5. Equipment Features
Figure 6. Other Features
Figure 7. Global POCT Molecular Diagnostics Technology Market Size by Application (2020-2031) & (US$ Million)
Figure 8. Global POCT Molecular Diagnostics Technology Market Share by Application: 2024 VS 2031
Figure 9. Hospital Case Studies
Figure 10. Decentralized Laboratory Case Studies
Figure 11. Other Case Studies
Figure 12. POCT Molecular Diagnostics Technology Report Years Considered
Figure 13. Global POCT Molecular Diagnostics Technology Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global POCT Molecular Diagnostics Technology Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global POCT Molecular Diagnostics Technology Market Share by Region: 2024 VS 2031
Figure 16. Global POCT Molecular Diagnostics Technology Market Share by Players in 2024
Figure 17. Global Top POCT Molecular Diagnostics Technology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in POCT Molecular Diagnostics Technology as of 2024)
Figure 18. The Top 10 and 5 Players Market Share by POCT Molecular Diagnostics Technology Revenue in 2024
Figure 19. North America POCT Molecular Diagnostics Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America POCT Molecular Diagnostics Technology Market Share by Country (2020-2031)
Figure 21. United States POCT Molecular Diagnostics Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada POCT Molecular Diagnostics Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe POCT Molecular Diagnostics Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe POCT Molecular Diagnostics Technology Market Share by Country (2020-2031)
Figure 25. Germany POCT Molecular Diagnostics Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France POCT Molecular Diagnostics Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. POCT Molecular Diagnostics Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy POCT Molecular Diagnostics Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia POCT Molecular Diagnostics Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Nordic Countries POCT Molecular Diagnostics Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific POCT Molecular Diagnostics Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific POCT Molecular Diagnostics Technology Market Share by Region (2020-2031)
Figure 33. China POCT Molecular Diagnostics Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan POCT Molecular Diagnostics Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea POCT Molecular Diagnostics Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia POCT Molecular Diagnostics Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India POCT Molecular Diagnostics Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia POCT Molecular Diagnostics Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America POCT Molecular Diagnostics Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America POCT Molecular Diagnostics Technology Market Share by Country (2020-2031)
Figure 41. Mexico POCT Molecular Diagnostics Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil POCT Molecular Diagnostics Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa POCT Molecular Diagnostics Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa POCT Molecular Diagnostics Technology Market Share by Country (2020-2031)
Figure 45. Turkey POCT Molecular Diagnostics Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia POCT Molecular Diagnostics Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. UAE POCT Molecular Diagnostics Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Danaher (Cepheid) Revenue Growth Rate in POCT Molecular Diagnostics Technology Business (2020-2025)
Figure 49. Roche Revenue Growth Rate in POCT Molecular Diagnostics Technology Business (2020-2025)
Figure 50. Abbott Revenue Growth Rate in POCT Molecular Diagnostics Technology Business (2020-2025)
Figure 51. bioMérieux Revenue Growth Rate in POCT Molecular Diagnostics Technology Business (2020-2025)
Figure 52. Hologic Revenue Growth Rate in POCT Molecular Diagnostics Technology Business (2020-2025)
Figure 53. Thermo Fisher Scientific Revenue Growth Rate in POCT Molecular Diagnostics Technology Business (2020-2025)
Figure 54. Bohui Innovation Revenue Growth Rate in POCT Molecular Diagnostics Technology Business (2020-2025)
Figure 55. AoBio Revenue Growth Rate in POCT Molecular Diagnostics Technology Business (2020-2025)
Figure 56. Shengxiang Bio Revenue Growth Rate in POCT Molecular Diagnostics Technology Business (2020-2025)
Figure 57. Kayoudi Revenue Growth Rate in POCT Molecular Diagnostics Technology Business (2020-2025)
Figure 58. Hangzhou Yousda Revenue Growth Rate in POCT Molecular Diagnostics Technology Business (2020-2025)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Oral Antianginal Drugs Market Outlook, In‑Depth Analysis & Forecast to 2031
Oct 21, 25
Global Polyester BCF Yarns Market Outlook, In‑Depth Analysis & Forecast to 2031
Oct 21, 25
Global Glass Mat Reinforced Thermoplastics (GMT) for Automotive Market Outlook, In‑Depth Analysis & Forecast to 2031
Oct 21, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232